Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 10:52 PM
Ignite Modification Date: 2025-12-24 @ 10:52 PM
NCT ID: NCT06922669
Eligibility Criteria: Inclusion Criteria: * A definite diagnosis of acute DILI; * 5×ULN ≤ TBIL level at baseline ≤ 20×ULN; * Age 18-80 years old; * Sign the informed consent form. Exclusion Criteria: * Other causes of liver injury, including viral hepatitis, cytomegalovirus infection, Epstein-Barr virus infection, Herpes virus infection, autoimmune liver disease, alcoholic liver disease, hypoxic/ischemic liver disease, Budd-Chiari syndrome, biliary tract disease, Wilson's disease, hemochromatosis, and α1-antitrypsin deficiency; * Immune checkpoint inhibitors or gynura segetum induced DILI; * Absolute contraindications to glucocorticoids, such as systemic mold infections or allergies; * A history of glucocorticoid therapy within 3 months before enrollment; * A history of diseases requiring glucocorticoid maintenance therapy, such as rheumatoid arthritis, systemic lupus erythematosus, systemic dermatomyositis, etc; * A history of liver transplantation; * Received artificial liver therapy before enrollment; * Malignant tumor of the liver, bile duct, pancreas or liver metastasis * Acute liver failure; * Renal dysfunction, creatinine Cr≥133μmol/L; * Neutrophil count \<1,000,000,000/L; * Active tuberculosis; * Severe cardiopulmonary diseases; * Recent surgery or trauma; * Mental illness; * Pregnancy or lactation; * Participated in other clinical studies within 3 months before enrollment; * Other conditions judged by the clinician to be inappropriate for study participation.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 80 Years
Study: NCT06922669
Study Brief:
Protocol Section: NCT06922669